Adamas: Adamas Pharmaceuticals gets grant for extended release amantadine for reducing sleep disturbances in parkinson's disease
Reduce OFF time in Parkinson's patients with Adamas Pharmaceuticals' patented method using extended-release amantadine. Optimal dosages for improved treatment outcomes.
Read full article »
CEO
Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
Read more